David Young - 16 Aug 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
23 Aug 2022, 16:30:49 UTC
Prior SEC filing
09 Aug 2022
Next SEC filing
03 Oct 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ David Young by Michael B. Kirwan, as Attorney-in-Fact

Key filing fact

David Young filed Form 4 for Processa Pharmaceuticals, Inc. (PCSA) on 23 Aug 2022.

Key facts

  • This page summarizes David Young's Form 4 filing for Processa Pharmaceuticals, Inc. (PCSA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 23 Aug 2022, 16:30.

Change

  • Previous filing in this sequence was filed on 09 Aug 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PCSA transaction

Common Stock

Gift

Transaction value
$0
Shares
-9,250
Change %
-2.4%
Price
$0.000000
Shares after
377,784
Date
16 Aug 2022
Ownership
Direct
PCSA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
573,568
Date
16 Aug 2022
Ownership
By Young-Plaisance Revocable Trust
PCSA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
694,591
Date
16 Aug 2022
Ownership
By Family Entities
PCSA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
37,504
Date
16 Aug 2022
Ownership
By CorLyst, LLC
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .